Vascular smooth muscle phenotypic diversity and function

Physiological Genomics

Volumn 42 A, Issue 3, 2010, Pages 169-187

  Fisher, Steven A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Myosin; Nitric oxide; Phasic; Phosphatase; Tonic; Vasomotion

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR GAMMA1; ACTIN; ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENOSINE TRIPHOSPHATE; ALPHA ACTIN; ALPHA ACTININ 1; BETA ACTIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; CALCIUM CHANNEL L TYPE; CALDESMON; CALPONIN; CARBOMETHOXYISOPROPYL ISOCYANIDE TECHNETIUM TC 99M; CYCLIC AMP; GUANYLATE KINASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; ISOPROTEIN; MESSENGER RNA; MIDOSTAURIN; MOLECULAR MOTOR; MYOSIN; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; NITRIC OXIDE; POTASSIUM CHANNEL; RHO KINASE; UNINDEXED DRUG;

AUTOCRINE EFFECT; BASIC LEUCINE ZIPPER MOTIF; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; COLLATERAL CIRCULATION; DIABETES MELLITUS; ENDOCRINE FUNCTION; GENE EXPRESSION; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE POTENTIAL; MOLECULAR GENETICS; MUSCLE FUNCTION; MYOFILAMENT; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REGULATORY SEQUENCE; REVIEW; SARCOPLASMIC RETICULUM; SENSITIVITY ANALYSIS; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD VESSELS; HEMODYNAMICS; HUMANS; HYPERTENSION; MODELS, BIOLOGICAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NEUROMUSCULAR DISEASES; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 78649736185     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00111.2010     Document Type: Review

References (248)

1. Alessi D, Macdougall LK, Sola MM, Ikebe M, Cohen P. The control of protein phosphatase-1 by targeting subunits. Eur J Biochem 210: 1023-1035, 1992.
2. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84: 935-986, 2004. (Pubitemid 38823771)
3. Andreasen D, Friis UG, Uhrenholt TR, Jensen BL, Skott O, Hansen PB. Coexpression of voltage-dependent calcium channels Cav1.2, 21a, and 21b in vascular myocytes. Hypertension 47: 735-741, 2006.
4. Anwar MA, Ju K, Docherty CC, Poston L, Nathanielsz PW. Developmental changes in reactivity of small femoral arteries in the fetal and postnatal baboon. Am J Obstet Gynecol 184: 707-712, 2001.
5. Arimura T, Suematsu N, Zhou YB, Nishimura J, Satoh S, Takeshita A, Kanaide H, Kimura A. Identification, characterization, and functional analysis of heart-specific myosin light chain phosphatase small subunit. J Biol Chem 276: 6073-6082, 2001.
6. Arner A, Lofgren M, Morano I. Smooth, slow and smart muscle motors. J Muscle Res Cell Motil 24: 165-173, 2003.
7. Babu GJ, Loukianov E, Loukianova T, Pyne GJ, Huke S, Osol G, Low RB, Paul RJ, Periasamy M. Loss of SM-B myosin affects muscle shortening velocity and maximal force development. Nat Cell Biol 3: 1025-1029, 2001.
8. Babu GJ, Pyne GJ, Zhou Y, Okwuchukuasanya C, Brayden JE, Osol G, Paul RJ, Low RB, Periasamy M. Isoform switching from SM-B to SM-A myosin results in decreased contractility and altered expression of thin filament regulatory proteins. Am J Physiol Cell Physiol 287: C723-C729, 2004.
9. Bakker ENTP, Sorop O, Spaan JAE, VanBavel E. Remodeling of resistance arteries in organoid culture is modulated by pressure and pressure pulsation and depends on vasomotion. Am J Physiol Heart Circ Physiol 286: H2052-H2056, 2004.
10. Barlow CA, Rose P, Pulver-Kaste RA, Lounsbury KM. Excitation- transcription coupling in smooth muscle. J Physiol 570: 59-64, 2006.
11. Barreau C, Paillard L, Mereau A, Osborne HB. Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. Biochimie 88: 515-525, 2006. (Pubitemid 43867902)
12. Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75: 19-37, 2006. (Pubitemid 44118024)
13. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81: 999-1030, 2001. (Pubitemid 32606665)
14. Bertoni S, Ballabeni V, Flammini L, Gobbetti T, Impicciatore M, Barocelli E. Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles. Neurogastroenterol Motil 20: 1234-1242, 2008.
15. Bertoni S, Gabella G, Ballabeni V, Ghirardi A, Impicciatore M, Barocelli E. Plasticity of rat small intestine after removal of a chronic mechanical obstruction. Neurogastroenterol Motil 18: 862-872, 2006. (Pubitemid 44201173)
16. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Ann Rev Biochem 72: 291-336, 2003.
17. Blue EK, Goeckeler ZM, Jin Y, Hou L, Dixon SA, Herring BP, Wysolmerski RB, Gallagher PJ. 220- and 130-kDa MLCKs have distinct tissue distributions and intracellular localization patterns. Am J Physiol Cell Physiol 282: C451-C460, 2002.
18. Bonnet S, Archer SL. Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension. Pharmacol Therapeut 115: 56-69, 2007.
19. 2+ sensitization in smooth muscle. J Biol Chem 279: 28998-29003, 2004.
20. Boutz PL, Chawla G, Stoilov P, Black DL. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev 21: 71-84, 2007. (Pubitemid 46089709)
21. Brimacombe KR, Ladd AN. Cloning and embryonic expression patterns of the chicken CELF family. Dev Dyn 236: 2216-2224, 2007.
22. Bruce L, Nixon GF. Increased sensitization of the myofilaments in rat neonatal portal vein: a potential mechanism. Exp Physiol 82: 985-993, 1997.
23. Buus CL, Pourageaud F, Fazzi GE, Janssen G, Mulvany MJ, De Mey JGR. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res 89: 180-186, 2001.
24. 2+ homeostasis and contractility in gallbladder smooth muscle. Am J Physiol Cell Physiol 296: C783-C791, 2009.
25. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 356: 830-840, 2007.
26. Cheng X, Liu J, Asuncion-Chin M, Blaskova E, Bannister JP, Dopico AM, Jaggar JH. A novel Ca(V)1.2 N terminus expressed in smooth muscle cells of resistance size arteries modifies channel regulation by auxiliary subunits. J Biol Chem 282: 29211-29221, 2007.
27. Chi M, Zhou Y, Vedamoorthyrao S, Babu GJ, Periasamy M. Ablation of smooth muscle myosin heavy chain SM2 increases smooth muscle contraction and results in postnatal death in mice. Proc Natl Acad Sci USA 105: 18614-18618, 2008.
28. Chilian WM. Coronary microcirculation in health and disease. Summary of an NHLBI workshop. Circulation 95: 522-528, 1997.
29. + currents Kir2.1 expression in renal afferent and efferent arterioles. J Am Soc Nephrol 19: 69-76, 2008.
30. Chu A, Murray JJ, Lin CC, Russell M, Hagen PO, Cobb FR. Preferential proximal coronary dilation by activators of guanylate cyclase in awake dogs. Am J Physiol Heart Circ Physiol 259: H340-H345, 1990.
31. Collardeau-Frachon S, Scoazec JY. Vascular development and differentiation during human liver organogenesis. Anat Rec (Hoboken) 291: 614-627, 2008.
32. Conti MA, Adelstein RS. Nonmuscle myosin II moves in new directions. J Cell Sci 121: 11-18, 2008.
33. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710, 2009.
34. Damianov A, Black DL. Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA 16: 405-416, 2010.
35. Damon DH. Sympathetic innervation promotes vascular smooth muscle differentiation. Am J Physiol Heart Circ Physiol 288: H2785-H2791, 2005.
36. Dauwalder B, Amaya-Manzanares F, Mattox W. A human homologue of the Drosophila sex determination factor transformer-2 has conserved splicing regulatory functions. Proc Natl Acad Sci USA 93: 9004-9009, 1996.
37. De Mey JGR, Schiffers PM, Hilgers RHP, Sanders MMW. Toward functional genomics of flow-induced outward remodeling of resistance arteries. Am J Physiol Heart Circ Physiol 288: H1022-H1027, 2005.
38. Delafontaine P, Song YH, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 24: 435-444, 2004. (Pubitemid 38326135)
39. Dirksen WP, Mohamed SA, Fisher SA. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element. J Biol Chem 278: 9722-9732, 2003.
40. Dirksen WP, Vladic F, Fisher SA. A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch. Am J Physiol Cell Physiol 278: C589-C600, 2000.
41. DiSanto ME, Cox RH, Wang Z, Chacko S. NH2-terminal-inserted myosin II heavy chain is expressed in smooth muscle of small muscular arteries. Am J Physiol Cell Physiol 272: C1532-C1542, 1997.
42. Dixon RE, Hwang SJ, Hennig GW, Ramsey KH, Schripsema JH, Sanders KM, Ward SM. Chlamydia infection causes loss of pacemaker cells and inhibits oocyte transport in the mouse oviduct. Biol Reprod 80: 665-673, 2009.
43. Docherty CC, Kalmar-Nagy J, Engelen M, Nathanielsz PW. Development of fetal vascular responses to endothelin-1 and acetylcholine in the sheep. Am J Physiol Regul Integr Comp Physiol 280: R554-R562, 2001.
44. Domkowski PW, Cockerham JT, Kot PA, Myers JL, Wallace RB, Hopkins RA. The role of N omega-nitro-L-arginine in modulation of pulmonary vascular tone in the maturing newborn pig. J Thorac Cardiovasc Surg 110: 1486-1492, 1995.
45. Drew JS, Murphy RA. Actin isoform expression, cellular heterogeneity, and contractile function in smooth muscle. Can J Physiol Pharmacol 75: 869-877, 1997.
46. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA, Ares M. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17: 187-193, 2010.
47. Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferator-activated receptor-gamma mediates effects in the vasculature. Circ Res 102: 283-294, 2008.
48. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 88: 1009-1086, 2008.
49. Edwards FR, Hirst GD, Silverberg GD. Inward rectification in rat cerebral arterioles; involvement of potassium ions in autoregulation. J Physiol 404: 455-466, 1988.
50. Ehmke H. Developmental physiology of the cardiovascular system. Am J Physiol Regul Integr Comp Physiol 282: R331-R333, 2002.
51. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MVG, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16: 1590-1598, 2009.
52. Eto M, Senba S, Morita F, Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410: 356-360, 1997.
53. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem 284: 35273-35277, 2009.
54. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HHHW, Stasch JP. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5: 755-768, 2006.
55. Fatigati V, Murphy RA. Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. J Biol Chem 259: 14383-14388, 1984. (Pubitemid 15222253)
56. Feletou M, Hoeffner U, Vanhoutte PM. Endothelium-dependent relaxing factors do not affect the smooth muscle of portal vein. Blood Vessels 26: 21-32, 1989.
57. Fetalvero KM, Zhang P, Shyu M, Young BT, Hwa J, Young RC, Martin KA. Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition. J Clin Invest 118: 3966-3979, 2008.
58. Figueroa XF, Isakson BE, Duling BR. Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) 19: 277-284, 2004.
59. Fineman JR, Wong J, Morin FC III, Wild LM, Soifer SJ. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest 93: 2675-2683, 1994.
60. Fisher SA, Ikebe M. Developmental and tissue distribution of expression of nonmuscle and smooth muscle isoforms of myosin light chain kinase. Biochem Biophys Res Commun 217: 696-703, 1995. (Pubitemid 26011764)
61. Fisher SA, Ikebe M, Brozovich FV. Endothelin-1 alters the contractile phenotype of cultured embryonic smooth muscle cells. Circ Res 80: 885-893, 1997.
62. Fodor AA, Aldrich RW. Convergent evolution of alternative splices at domain boundaries of the BK channel. Annu Rev Physiol 71: 19-36, 2009.
63. Fountain SJ, Cheong A, Flemming R, Mair L, Sivaprasadarao A, Beech DJ. Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle. J Physiol 556: 29-42, 2004.
64. Frei E, Huster M, Smital P, Schlossmann J, Hofmann F, Wegener JW. Calcium-dependent and Calcium-independent inhibition of contraction by cGMP/cGKI in intestinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 297: G834-G839, 2009.
65. Gabella G. Development of visceral smooth muscle. Results Probl Cell Differ 38: 1-37, 2002.
66. Gallagher PJ, Herring BP, Griffin SA, Stull JT. Molecular characterization of a mammalian smooth muscle myosin light chain kinase. J Biol Chem 266: 23936-23944, 1991.
67. Garland JG, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol 105: 429-435, 1992.
68. Given AM, Ogut O, Brozovich FV. MYPT1 mutants demonstrate the importance of aa 888-928 for the interaction with PKGIα. Am J Physiol Cell Physiol 292: C432-C439, 2007.
69. Goehler LE, Sternini C. Calcitonin gene-related peptide innervation of the rat hepatobiliary system. Peptides 17: 209-217, 1996. (Pubitemid 26122775)
70. Gong MC, Cohen P, Kitazawa T, Ikebe M, Masuo M, Somlyo AP, Somlyo AV. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem 267: 14662-14668, 1992.
71. Goyal RK, Chaudhury A. Mounting evidence against the role of ICC in neurotransmission to smooth muscle in the gut. Am J Physiol Gastrointest Liver Physiol 298: G10-G13, 2010.
72. Gromak N, Rideau A, Southby J, Scadden ADJ, Gooding C, Huttelmaier S, Singer RH, Smith CWJ. The PTB interacting protein raver1 regulates alpha-tropomyosin alternative splicing. EMBO J 22: 6356-6364, 2003.
73. Haddock RE, Hill CE. Rhythmicity in arterial smooth muscle. J Physiol 566: 645-656, 2005.
74. Haines N, Wang S, Undar A, Alkan T, Akcevin A. Clinical outcomes of pulsatile and non-pulsatile mode of perfusion. J Extra Corpor Technol 41: 26-29, 2009.
75. Hansen PB, Jensen BL, Andreasen D, Skott O. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res 89: 630-638, 2001.
76. Hasegawa Y, Morita F. Role of 17-kDa essential light chain isoforms of aorta smooth muscle myosin. J Biochem (Tokyo) 111: 804-809, 1992.
77. Haworth SG. Development of the normal and hypertensive pulmonary vasculature. Exp Physiol 80: 843-853, 1995.
78. Hayashi Y, Senba S, Yazawa M, Brautigan DL, Eto M. Defining the structural determinants and a potential mechanism for inhibition of myosin phosphatase by the protein kinase C-potentiated inhibitor protein of 17 kDa. J Biol Chem 276: 39858-39863, 2001. (Pubitemid 37391396)
79. Helper DJ, Lash JA, Hathaway DR. Distribution of isoelectric variants of the 17,000-dalton myosin light chain in mammalian smooth muscle. J Biol Chem 263: 15748-15753, 1988.
80. Herring BP, El Mounayri O, Gallagher PJ, Yin F, Zhou J. Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues. Am J Physiol Cell Physiol 291: C817-C827, 2006.
81. Herring BP, Lyons GE, Hoggatt AM, Gallagher PJ. Telokin expression is restricted to smooth muscle tissues during mouse development. Am J Physiol Cell Physiol 280: C12-C21, 2001.
82. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90: 291-366, 2010.
83. High FA, Epstein JA. The multifaceted role of Notch in cardiac development and disease. Nat Rev Genet 9: 49-61, 2008.
84. High FA, Zhang M, Proweller A, Tu L, Parmacek MS, Pear WS, Epstein JA. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest 117: 353-363, 2007. (Pubitemid 46203964)
85. + channels (BKCa) and arteriolar myogenic signaling. FEBS Lett 584: 2033-2042, 2010.
86. Hill-Eubanks DC, Gomez MF, Stevenson AS, Nelson MT. NFAT regulation in smooth muscle. Trends Cardiovasc Med 13: 56-62, 2003.
87. Ho TH, Charlet B, Poulos MG, Singh G, Swanson MS, Cooper TA. Muscleblind proteins regulate alternative splicing. EMBO J 23: 3103-3112, 2004.
88. Hofmann F, Feil R, Kleppisch T, Schlossmann J. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86: 1-23, 2006.
89. Hong H, Aksenov S, Guan X, Fallon JT, Waters D, Chen C. Remodeling of small intramyocardial coronary arteries distal to a severe epicardial coronary artery stenosis. Arterioscler Thromb Vasc Biol 22: 2059-2065, 2002.
90. Hwa JJ, Ghibaudi L, Williams P, Chatterjee M. Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am J Physiol Heart Circ Physiol 266: H952-H958, 1994.
91. Injeti ER, Sandoval RJ, Williams JM, Smolensky AV, Ford LE, Pearce WJ. Maximal stimulation-induced in situ myosin light chain kinase activity is upregulated in fetal compared with adult ovine carotid arteries. Am J Physiol Heart Circ Physiol 295: H2289-H2298, 2008.
92. Ito M, Dabrowska R, Guerrerio V Jr, Hartshorne DJ. Identification in turkey gizzard of an acidic protein related to the C-terminal portion of smooth muscle myosin light chain kinase. J Biol Chem 264: 13971-13974, 1989.
93. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 259: 197-209, 2004.
94. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation 12: 113-127, 2005.
95. Kakkar R, Ye B, Stoller DA, Smelley M, Shi NQ, Galles K, Hadhazy M, Makielski JC, McNally EM. Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ Res 98: 682-689, 2006. (Pubitemid 43755288)
96. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, Cooper TA. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci USA 105: 20333-20338, 2008.
97. Kanadia RN, Cepko CL. Alternative splicing produces high levels of noncoding isoforms of bHLH transcription factors during development. Genes Dev 24: 229-234, 2010.
98. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscle-blind knockout model for myotonic dystrophy. Science 302: 1978-1980, 2003.
99. Karagiannis P, Babu GJ, Periasamy M, Brozovich FV. Myosin heavy chain isoform expression regulates shortening velocity in smooth muscle: studies using an SMB KO mouse line. J Muscle Res Cell Motil 25: 149-158, 2004.
100. Karim SM, Rhee AY, Given AM, Faulx MD, Hoit BD, Brozovich FV. Vascular reactivity in heart failure: role of myosin light chain phosphatase. Circ Res 95: 612-618, 2004.
101. Kelley CA, Takahashi M, Yu JH, Adelstein RS. An insert of seven amino acids confers functional differences between smooth muscle myosins from the intestines and vasculature. J Biol Chem 268: 12848-12854, 1993.
102. Khatri JJ, Joyce KM, Brozovich FV, Fisher SA. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276: 37250-37257, 2001. (Pubitemid 37384143)
103. 2+ and decreased cGMP-induced relaxation. Proc Natl Acad Sci USA 103: 2440-2445, 2006.
104. Kim KY, Kovacs M, Kawamoto S, Sellers JR, Adelstein RS. Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C. J Biol Chem 280: 22769-22775, 2005.
105. Koeppen M, Feil R, Siegl D, Feil S, Hofmann F, Pohl U, de Wit C. cGMP-dependent protein kinase mediates NO- but not acetylcholine-induced dilations in resistance vessels in vivo. Hypertension 44: 952-955, 2004.
106. Komatsu S, Miyazaki K, Tuft RA, Ikebe M. Translocation of telokin by cGMP signaling in smooth muscle cells. Am J Physiol Cell Physiol 283: C752-C761, 2002.
107. Krenz M, Sanbe A, Bouyer-Dalloz F, Gulick J, Klevitsky R, Hewett TE, Osinska HE, Lorenz JN, Brosseau C, Federico A, Alpert NR, Warshaw DM, Perryman MB, Helmke SM, Robbins J. Analysis of myosin heavy chain functionality in the heart. J Biol Chem 278: 17466-17474, 2003.
108. Kuo L, Davis MJ, Chilian WM. Longitudinal gradients for endothelium-dependent and -independent vascular responses in the coronary microcirculation. Circulation 92: 518-525, 1995.
109. Kuroyanagi H. Fox-1 family of RNA-binding proteins. Cell Mol Life Sci 66: 3895-3907, 2009.
110. Ladd AN, Stenberg MG, Swanson MS, Cooper TA. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn 233: 783-793, 2005.
111. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405-407, 1986.
112. Liang M. MicroRNA: a new entrance to the broad paradigm of systems molecular medicine. Physiol Genomics 38: 113-115, 2009.
113. 2+ channels in cardiac and smooth muscles. Cardiovasc Res 68: 197-203, 2005.
114. Liao P, Yu D, Li G, Yong TF, Soon JL, Chua YL, Soong TW. A smooth muscle Cav1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine. J Biol Chem 282: 35133-35142, 2007.
115. Lim KM, Kim IS, Choi SW, Min BG, Won YS, Kim HY, Shim EB. Computational analysis of the effect of the type of LVAD flow on coronary perfusion and ventricular afterload. J Physiol Sci 59: 307-316, 2009.
116. Lincoln TM, Komalavilias P. Cyclic GMP-Mediated Signaling Mechanisms in Smooth Muscle. In: Nitric Oxide Biology and Pathobiology, edited by Ignarro LJ. San Diego, CA: Academic, 2000, p. 401-442.
117. Liu SF, Hislop AA, Haworth SG, Barnes PJ. Developmental changes in endothelium-dependent pulmonary vasodilatation in pigs. Br J Pharmacol 106: 324-330, 1992.
118. Ljung B, Lundberg JM, Dahlstrom A, Kjellstedt A. Structural and functional ontogenetic development of the rat portal vein after neonatal 6-hydroxydopamine treatment. Acta Physiol Scand 106: 271-279, 1979.
119. Lofgren M, Fagher K, Woodard G, Arner A. Effects of thyroxine on myosin isoform expression and mechanical properties in guinea-pig smooth muscle. J Physiol 543: 757-766, 2002.
120. Long X, Bell RD, Gerthoffer WT, Zlokovic BV, Miano JM. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler Thromb Vasc Biol 28: 1505-1510, 2008.
121. Loukianov E, Loukianova T, Periasamy M. Myosin heavy chain isoforms in smooth muscle. Comp Biochem Physiol B 117: 13-18, 1997.
122. Low RB, Mitchell J, Woodcock-Mitchell J, Rovner AS, White SL. Smooth-muscle myosin heavy-chain SM-B isoform expression in developing and adult rat lung. Am J Respir Cell Mol Biol 20: 651-657, 1999. (Pubitemid 129495653)
123. Lu Y, Zhang H, Gokina N, Mandala M, Sato O, Ikebe M, Osol G, Fisher SA. Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy. Am J Physiol Cell Physiol 294: C564-C571, 2008.
124. Madden JA, Dantuma MW, Sorokina EA, Weihrauch D, Kleinman JG. Telokin expression and the effect of hypoxia on its phosphorylation status in smooth muscle cells from small and large pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 294: L1166-L1173, 2008.
125. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 27: 1248-1258, 2007.
126. Malmqvist U, Arner A. Contractile properties during development of hypertrophy of the smooth muscle in the rat portal vein. Acta Physiol Scand 133: 49-61, 1988.
127. Malmqvist U, Arner A. Isoform distribution and tissue contents of contractile and cytoskeletal proteins in hypertrophied smooth muscle from rat portal vein. Circ Res 66: 832-845, 1990.
128. Malmqvist U, Arner A. Correlation between isoform composition of the 17 kDa myosin light chain and maximal shortening velocity in smooth muscle. Pflügers Arch 418: 523-530, 1991.
129. Marshall JM. Vertebrate smooth muscle. In: Medical Physiology, edited by Mountcastle VB. St. Louis, MO: C. V. Mosby, 1980, p. 120-148.
130. Marston S, El-Mezgueldi M. Role of tropomyosin in the regulation of contraction in smooth muscle. Adv Exp Med Biol 644: 110-123, 2008.
131. Martin C, Gunning P. Isoform sorting of tropomyosins. Adv Exp Med Biol 644: 187-200, 2008.
132. Matchkov VV, Larsen P, Bouzinova EV, Rojek A, Boedtkjer DMB, Golubinskaya V, Pedersen FS, Aalkjaer C, Nilsson H. Bestrophin-3 (vitelliform macular dystrophy 2-like 3 protein) is essential for the cGMP-dependent calcium-activated chloride conductance in vascular smooth muscle cells. Circ Res 103: 864-872, 2008.
133. Matkovich SJ, Zhang Y, Van Booven DJ, Dorn GW. Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators: application to Galphaq. Circ Res 106: 1459-1467, 2010.
134. Matlin AJ, Clark F, Smith CWJ. Understanding alternative splicing: toward a cellular code. Nat Rev Mol Cell Biol 6: 386-398, 2005. (Pubitemid 40637856)
135. McHugh KM. Molecular analysis of gastrointestinal smooth muscle development. J Pediatr Gastroenterol Nutr 23: 379-394, 1996. (Pubitemid 26423766)
136. McMurphy DS, Ljung B. Neuroeffector maturity of portal veins from newborn rats, rabbits, cats and guinea pigs. Acta Physiol Scand 102: 218-223, 1978.
137. Meyer C, de Vries G, Davidge ST, Mayes DC. Reassessing the mathematical modeling of the contribution of vasomotion to vascular resistance. J Appl Physiol 92: 888-889, 2002.
138. Miano JM, Long X, Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292: C70-C81, 2007.
139. Michael SK, Surks HK, Wang Y, Zhu Y, Blanton R, Jamnongjit M, Aronovitz M, Baur W, Ohtani K, Wilkerson MK, Bonev AD, Nelson MT, Karas RH, Mendelsohn ME. High blood pressure arising from a defect in vascular function. Proc Natl Acad Sci USA 105: 6702-6707, 2008.
140. Moga MA, Nakamura T, Robbins J. Genetic approaches for changing the heart and dissecting complex syndromes. J Mol Cell Cardiol 45: 148-155, 2008.
141. Morano I. Tuning smooth muscle contraction by molecular motors. J Mol Med 81: 481-487, 2003.
142. Moreau R, Lebrec D. Molecular and structural basis of portal hypertension. Clin Liver Dis 10: 445-457, 2006. (Pubitemid 44895401)
143. Murphy RA, Rembold CM. The latch-bridge hypothesis of smooth muscle contraction. Can J Physiol Pharmacol 83: 857-864, 2005.
144. Nagao T, Illiano S, Vanhoutte PM. Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. Am J Physiol Heart Circ Physiol 263: H1090-H1094, 1992.
145. Nakahata S, Kawamoto S. Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucl Acids Res 33: 2078-2089, 2005.
146. Nakamura K, Koga Y, Sakai H, Homma K, Ikebe M. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res 101: 712-722, 2007.
147. Nankervis CA, Dunaway DJ, Nowicki PT. Determinants of terminal mesenteric artery resistance during the first postnatal month. Am J Physiol Gastrointest Liver Physiol 280: G678-G686, 2001.
148. Nankervis CA, Reber KM, Nowicki PT. Age-dependent changes in the postnatal intestinal microcirculation. Microcirculation 8: 377-387, 2001.
149. 2+ sensitivity in ovine cranial arteries. Am J Physiol Heart Circ Physiol 280: H1019-H1028, 2001.
150. Nelson MT, Rubart M, Santana LF, Boney AD, Knot HJ, Lederer WJ. Relaxation of arterial smooth muscle by calcium sparks. Science 270: 633-637, 1995.
151. Nilsson H, Aalkjaer C. Vasomotion: mechanisms and physiological importance. Mol Interv 3: 79-89, 2003.
152. Niro C, Demignon J, Vincent S, Liu Y, Giordani J, Sgarioto N, Favier M, Guillet-Deniau I, Blais A, Maire P. Six1 and Six4 gene expression is necessary to activate the fast-type muscle gene program in the mouse primary myotome. Dev Biol 338: 168-182, 2010.
153. Nishikawa Y, Stepp DW, Chilian WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol Heart Circ Physiol 277: H1252-H1259, 1999.
154. Nystoriak MA, Murakami K, Penar PL, Wellman GC. Cav1.2 splice variant with exon 9* is critical for regulation of cerebral artery diameter. Am J Physiol Heart Circ Physiol 297: H1820-H1828, 2009.
155. O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet 13: 2505-2518, 2004.
156. Ody M, Thievent A, Millet M, Connat JL. Postnatal development of the rat portal vein: correlation with occurrence of peptidergic innervation. Cell Tissue Res 272: 303-314, 1993. (Pubitemid 23156861)
157. Ogut O, Yuen SL, Brozovich FV. Regulation of the smooth muscle contractile phenotype by nonmuscle myosin. J Muscle Res Cell Motil 28: 409-414, 2007.
158. Ogut O, Brozovich FV. Determinants of the contractile properties in the embryonic chicken gizzard and aorta. Am J Physiol Cell Physiol 279: C1722-C1732, 2000.
159. Orengo JP, Cooper TA. Alternative splicing in disease. Adv Exp Med Biol 623: 212-223, 2007.
160. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517, 1995.
161. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004. (Pubitemid 38823766)
162. Owens GK, Thompson MM. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. J Biol Chem 261: 13373-13380, 1986.
163. Pannen BH, Bauer M. Differential regulation of hepatic arterial and portal venous vascular resistance by nitric oxide and carbon monoxide in rats. Life Sci 62: 2025-2033, 1998. (Pubitemid 28239715)
164. + channels in vascular smooth muscle cells. Pflügers Arch 457: 137-147, 2008.
165. Parmacek MS. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res 100: 633-644, 2007.
166. 2+-binding domain. Eur J Biochem 210: 801-809, 1992.
167. Parthimos D, Haddock RE, Hill CE, Griffith TM. Dynamics of a three-variable nonlinear model of vasomotion: comparison of theory and experiment. Biophys J 93: 1534-1556, 2007.
168. Pascual M, Vicente M, Monferrer L, Artero R. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 74: 65-80, 2006.
169. Patzak A, Petzhold D, Wronski T, Martinka P, Babu GJ, Periasamy M, Haase H, Morano I. Constriction velocities of renal afferent and efferent arterioles of mice are not related to SMB expression. Kidney Int 68: 2726-2734, 2005.
170. Payne MC, Zhang HY, Prosdocimo T, Joyce KM, Koga Y, Ikebe M, Fisher SA. Myosin phosphatase isoform switching in vascular smooth muscle development. J Mol Cell Cardiol 40: 274-282, 2006. (Pubitemid 43152383)
171. Payne MC, Zhang HY, Shirasawa Y, Koga Y, Ikebe M, Benoit JN, Fisher SA. Dynamic changes in expression of myosin phosphatase in a model of portal hypertension. Am J Physiol Heart Circ Physiol 286: H1801-H1810, 2004.
172. Peng H, Matchkov V, Ivarsen A, Aalkjar C, Nilsson H. Hypothesis for the initiation of vasomotion. Circ Res 88: 810-815, 2001.
173. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17: 3045-3051, 1998.
174. Pfitzer G, Merkel L, Ruegg JC, Hofmann F. Cyclic GMP-dependent protein kinase relaxes skinned fibers from guinea pig taenia coli but not from chicken gizzard. Pflügers Arch 407: 87-91, 1986.
175. Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741, 1998.
176. Pipes GCT, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20: 1545-1556, 2006.
177. Pistea A, Bakker EN, Spaan JA, VanBavel E. Flow inhibits inward remodeling in cannulated porcine small coronary arteries. Am J Physiol Heart Circ Physiol 289: H2632-H2640, 2005.
178. Ploug KB, Baun M, Hay-Schmidt A, Olesen J, Jansen-Olesen I. Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues. Eur J Pharmacol 637: 109-117, 2010.
179. Popel AS, Goldman D, Vadapalli A. Modeling of oxygen diffusion from the blood vessels to intracellular organelles. Adv Exp Med Biol 530: 485-495, 2003.
180. Poulsen AN, Wulf H, Hay-Schmidt A, Jansen-Olesen I, Olesen J, Klaerke DA. Differential expression of BK channel isoforms and beta-subunits in rat neuro-vascular tissues. Biochim Biophys Acta 1788: 380-389, 2009.
181. Pourageaud F, De Mey JG. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol Heart Circ Physiol 273: H1699-H1706, 1997.
182. Pourageaud F, De Mey JG. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am J Physiol Heart Circ Physiol 274: H1301-H1307, 1998. (Pubitemid 128734724)
183. Quayle JM, Dart C, Standen NB. The properties and distribution of inward rectifier potassium currents in pig coronary arterial smooth muscle. J Physiol 494: 715-726, 1996. (Pubitemid 26278849)
184. Reber KM, Nankervis CA, Nowicki PT. Newborn intestinal circulation. Physiol Pathophysiol Clin Perinatol 29: 23-39, 2002.
185. Rhee AY, Ogut O, Brozovich FV. Nonmuscle myosin, force maintenance, and the tonic contractile phenotype in smooth muscle. Pflügers Arch 452: 766-774, 2006.
186. Sanders KM, Ward SM. Interstitial cells of Cajal: a new perspective on smooth muscle function. J Physiol 576: 721-726, 2006.
187. 2+, myosin light chain phosphorylation, and contractile tone in ovine cerebral arteries. Am J Physiol Heart Circ Physiol 293: H2183-H2192, 2007.
188. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
189. Schiaffino S, Sandri M, Murgia M. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 22: 269-278, 2007.
190. Sellke FW, Myers PR, Bates JN, Harrison DG. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol Heart Circ Physiol 258: H515-H520, 1990.
191. Seppey D, Sauser R, Koenigsberger M, Beny JL, Meister JJ. Does the endothelium abolish or promote arterial vasomotion in rat mesenteric arteries? Explanations for the seemingly contradictory effects. J Vasc Res 45: 416-426, 2008.
192. Sharma AK, Zhou GP, Kupferman J, Surks HK, Christensen EN, Chou JJ, Mendelsohn ME, Rigby AC. Probing the interaction between the coiled coil leucine zipper of cGMP-dependent protein kinase Ialpha and the C terminus of the myosin binding subunit of the myosin light chain phosphatase. J Biol Chem 283: 32860-32869, 2008.
193. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28: 703-711, 1996.
194. Shiraishi M, Wang X, Walsh MP, Kargacin G, Loutzenhiser K, Loutzenhiser R. Myosin heavy chain expression in renal afferent and efferent arterioles: relationship to contractile kinetics and function. FASEB J 17: 2284-2286, 2003.
195. Shirangi TR, McKeown M. Sex in flies: what 'body-mind' dichotomy? Dev Biol 306: 10-19, 2007.
196. Shukla S, Fisher SA. Tra2beta as a novel mediator of vascular smooth muscle diversification. Circ Res 103: 485-492, 2008.
197. Shukla S, Gatto-Konczak F, Breathnach R, Fisher SA. Competition of PTB with TIA proteins for binding to a U-rich cis-element determines tissue-specific splicing of the myosin phosphatase targeting subunit 1. RNA 11: 1725-1736, 2005. (Pubitemid 41505547)
198. Shukla S, Dirksen WP, Joyce KM, Guiner-Blanvillain CL, Breathnach R, Fisher SA. TIA proteins are necessary but not sufficient for the tissue-specific splicing of the myosin phosphatase targeting subunit 1. J Biol Chem 279: 13668-13676, 2004.
199. Sobue K, Hayashi K, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 190: 105-118, 1999.
200. Solomon V, Goldberg AL. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 271: 26690-26697, 1996.
201. Somlyo AV, Somlyo AP. Electromechanical and pharmacomechanical coupling in vascular smooth muscle. J Pharmacol Exper Therapeut 159: 129-145, 1968.
202. Sorop O, Bakker ENTP, Pistea A, Spaan JAE, VanBavel E. Calcium channel blockade prevents pressure-dependent inward remodeling in isolated subendocardial resistance vessels. Am J Physiol Heart Circ Physiol 291: H1236-H1245, 2006.
203. Sorop O, Merkus D, de Beer VJ, Houweling B, Pistea A, McFalls EO, Boomsma F, van Beusekom HM, van der Giessen WJ, VanBavel E, Duncker DJ. Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis. Circ Res 102: 795-803, 2008.
204. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: 19-31, 2004. (Pubitemid 39349317)
205. Stepp DW, Belin de Chantemele EJ. Structural remodeling in the limb circulation: impact of obesity and diabetes. Microcirculation 14: 311-316, 2007.
206. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 286: 1583-1587, 1999.
207. Szymanski PT, Szymanska G, Goyal RK. Differences in calmodulin and calmodulin-binding proteins in phasic and tonic smooth muscles. Am J Physiol Cell Physiol 282: C94-C104, 2002. (Pubitemid 34662556)
208. Szymanski PT, Chacko TK, Rovner AS, Goyal RK. Differences in contractile protein content and isoforms in phasic and tonic smooth muscles. Am J Physiol Cell Physiol 275: C684-C692, 1998.
209. Tacke R, Tohyama M, Ogawa S, Manley JL. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93: 139-148, 1998. (Pubitemid 28173559)
210. Tang ZZ, Liang MC, Lu S, Yu D, Yu CY, Yue DT, Soong TW. Transcript scanning reveals novel and extensive splice variations in human L-type voltage-gated calcium channel, Cav1.2 alpha1 subunit. J Biol Chem 279: 44335-44343, 2004.
211. Tanko LB, Matrougui K. Can we apply results from large to small arteries? Circ Res 90: 68e, 2002.
212. Thievent A, Connat JL. Cytoskeletal features in longitudinal and circular smooth muscles during development of the rat portal vein. Cell Tissue Res 279: 199-208, 1995.
213. Thorneloe KS, Nelson MT. Ion channels in smooth muscle: regulators of intracellular calcium and contractility. Can J Physiol Pharmacol 83: 215-242, 2005.
214. Thyberg J, Blomgren K. Effects of proteasome and calpain inhibitors on the structural reorganization and proliferation of vascular smooth muscle cells in primary culture. Lab Invest 79: 1077-1088, 1999. (Pubitemid 29444538)
215. Tian L, Coghill LS, MacDonald SH, Armstrong DL, Shipston MJ. Leucine zipper domain targets cAMP-dependent protein kinase to mammalian BK channels. J Biol Chem 278: 8669-8677, 2003. (Pubitemid 36800623)
216. Tian L, Duncan RR, Hammond MS, Coghill LS, Wen H, Rusinova R, Clark AG, Levitan IB, Shipston MJ. Alternative splicing switches potassium channel sensitivity to protein phosphorylation. J Biol Chem 276: 7717-7720, 2001.
217. Travis AR, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS, Sobieski M, Undar A, Farrar DJ, Koenig SC. Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device. J Thorac Cardiovasc Surg 133: 517-524, 2007.
218. Ts'ao CH, Glagov S, Kelsey BF. Structure of mammalian portal vein: postnatal establishment of two mutually perpendicular medial muscle zones in the rat. Anat Rec 171: 457-470, 1971.
219. Tsai MC, Chen L, Zhou J, Tang Z, Hsu TF, Wang Y, Shih YT, Peng HH, Wang N, Guan Y, Chien S, Chiu JJ. Shear stress induces synthetic-to-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator- activated receptor alpha/delta activations by prostacyclin released by sheared endothelial cells. Circ Res 105: 471-480, 2009.
220. Undar A. Myths and truths of pulsatile and nonpulsatile perfusion during acute and chronic cardiac support. Artif Organs 28: 439-443, 2004.
221. Undar A. Benefits of pulsatile flow during and after cardiopulmonary bypass procedures. Artif Organs 29: 688-690, 2005. (Pubitemid 41583580)
222. Unthank JL, Nixon JC, Burkhart HM, Fath SW, Dalsing MC. Early collateral and microvascular adaptations to intestinal artery occlusion in rat. Am J Physiol Heart Circ Physiol 271: H914-H923, 1996.
223. Uvelius B, Arner A, Johansson B. Structural and mechanical alterations in hypertrophic venous smooth muscle. Acta Physiol Scand 112: 463-471, 1981.
224. Van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376, 2007. (Pubitemid 47494334)
225. Van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17: 662-673, 2009.
226. Van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579, 2007. (Pubitemid 46683138)
227. Vrhovski B, Theze N, Thiebaud P. Structure and evolution of tropomyosin genes. Adv Exp Med Biol 644: 6-26, 2008.
228. Waites GT, Graham IR, Jackson P, Millake DB, Patel B, Blanchard AD, Weller PA, Eperon IC, Critchley DR. Mutually exclusive splicing of calcium-binding domain exons in chick alpha-actinin. J Biol Chem 267: 6263-6271, 1992.
229. 2+-desensitizing effect in smooth muscle. J Biol Chem 276: 24519-24524, 2001.
230. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res 98: 868-878, 2006. (Pubitemid 43755239)
231. Wang W, Nepiyushchikh Z, Zawieja DC, Chakraborty S, Zawieja SD, Gashev AA, Davis MJ, Muthuchamy M. Inhibition of myosin light chain phosphorylation decreases rat mesenteric lymphatic contractile activity. Am J Physiol Heart Circ Physiol 297: H726-H734, 2009.
232. Werner GS, Ferrari M, Richartz BM, Gastmann O, Figulla HR. Microvascular dysfunction in chronic total coronary occlusions. Circulation 104: 1129-1134, 2001. (Pubitemid 32830396)
233. Wesselman JP, Kuijs R, Hermans JJ, Janssen GM, Fazzi GE, van Essen H, Evelo CT, Struijker-Boudier HA, De Mey JG. Role of the RhoA/Rho kinase system in flow-related remodeling of rat mesenteric small arteries in vivo. J Vasc Res 41: 277-290, 2004.
234. Wetzel U, Lutsch G, Haase H, Ganten U, Morano I. Expression of smooth muscle myosin heavy chain B in cardiac vessels of normotensive and hypertensive rats. Circ Res 83: 204-209, 1998.
235. Wieland T, Mittmann C. Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther 97: 95-115, 2003.
236. 2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 535: 553-564, 2001.
237. Wooldridge AA, MacDonald JA, Erdodi F, Ma C, Borman MA, Hartshorne DJ, Haystead TAJ. Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of serine 695 in response to cyclic nucleotides. J Biol Chem 279: 34496-34504, 2004. (Pubitemid 39318077)
238. Wray S, Burdyga T. Sarcoplasmic reticulum function in smooth muscle. Physiol Rev 90: 113-178, 2010.
239. Wu KC, Jin JP. Calponin in non-muscle cells. Cell Biochem Biophys 52: 139-148, 2008.
240. Wu X, Haystead TA, Nakamoto RK, Somlyo AV, Somlyo AP. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase. J Biol Chem 273: 11362-11369, 1998.
241. Xie J, Black DL. A camk iv responsive RNA element mediates depolarization-induced alternative splicing of ion channels. Nature 410: 936-939, 2001.
242. Xie J, McCobb DP. Control of alternative splicing of potassium channels by stress hormones. Science 280: 443-446, 1998. (Pubitemid 28208168)
243. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 23: 2166-2178, 2009.
244. Yang Y, Murphy TV, Ella SR, Grayson TH, Haddock R, Hwang YT, Braun AP, Peichun G, Korthuis RJ, Davis MJ, Hill MA. Heterogeneity in function of small artery smooth muscle BKCa: involvement of the α-1-subunit. J Physiol 587: 3025-3044, 2009.
245. +-mediated vasodilation. Circ Res 87: 160-166, 2000.
246. Zhang H, Fisher SA. Conditioning effect of blood flow on resistance artery smooth muscle myosin phosphatase. Circ Res 100: 730-737, 2007.
247. Zhang H, Pakeerappa P, Lee HJ, Fisher SA. Induction of PDE5 and de-sensitization to endogenous NO signaling in a systemic resistance artery under altered blood flow. J Mol Cell Cardiol 47: 57-65, 2009.
248. Zhu N, Eghbali M, Helguera G, Song M, Stefani E, Toro L. Alternative splicing of Slo channel gene programmed by estrogen, progesterone and pregnancy. FEBS Lett 579: 4856-4860, 2005.